Multidrug resistant tuberculosis is a public health crisis. In 2020, only 1 in 3 people with drug resistant TB accessed treatment.

On this epsiode of Microbe Mail, Dr Sarah Stacey and I talk about treatment of MDR TB - why and how the regimens have changed, how to monitor patients on treatment and when to seek advice from an expert.

South African Rifampicin Resistant TB Treatment Guidelines

About our Guest: Dr Sarah Stacey

I am an infectious diseases specialist and I run a busy urban clinic at a tertiary site in Johannesburg and a busy infectious diseases ward – until a fire interrupted our services, that is… We are starting to get up and running again and hopefully will be back to capacity soon. The majority of our admissions to the infectious diseases ward are still HIV related and we still

see advanced disease in patients never on or defaulting ART. I have a broad range of interests within the scope of infectious diseases. I have an interest in improving and simplifying diagnostic tests in TB, particularly in HIV-positive patients in whom TB diagnosis continues to be challenging. I also have a particular interest in advancing proper antimicrobial stewardship and the implementation of programmes to improve antibiotic prescribing. I founded the CMJAH Antimicrobial Stewardship Programme and I and my colleagues on the committee are in the process of expanding the programme at the hospital which can be at times both rewarding and thankless... but a worthwhile fight!

instagram: sarahstacey15

twitter: @SarahLynnStace1

facebook: sarah.stacey.1297

Visit the Microbe Mail website to sign up for updates

E-mail: mail.microbe@gmail.com

YouTube: Microbe Mail

Instagram: Microbe_Mail 

Facebook: Microbe Mail

Twitter: @microbemail